These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 18715645

  • 1. Humoral immune responsiveness to a defined epitope on factor VIII before and after B cell ablation with rituximab.
    Kessel C, Königs C, Linde R, Escuriola-Ettinghausen C, Stoll H, Klingebiel T, Dietrich U, Kreuz W.
    Mol Immunol; 2008 Nov; 46(1):8-15. PubMed ID: 18715645
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Epitope mapping via selection of anti-FVIII antibody-specific phage-presented peptide ligands that mimic the antibody binding sites.
    Kahle J, Orlowski A, Stichel D, Becker-Peters K, Kabiri A, Healey JF, Brettschneider K, Naumann A, Scherger AK, Lollar P, Schwabe D, Königs C.
    Thromb Haemost; 2015 Feb; 113(2):396-405. PubMed ID: 25520269
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Factor VIII-specific B cell responses in haemophilia A patients with inhibitors.
    van Helden PM, Van Haren SD, Fijnvandraat K, van den Berg HM, Voorberg J.
    Haemophilia; 2010 May; 16(102):35-43. PubMed ID: 20536984
    [Abstract] [Full Text] [Related]

  • 13. The use of factor VIII/von Willebrand factor concentrate for immune tolerance induction in haemophilia A patients with high-titre inhibitors: association of clinical outcome with inhibitor epitope profile.
    Greninger DA, Saint-Remy JM, Jacquemin M, Benhida A, DiMichele DM.
    Haemophilia; 2008 Mar; 14(2):295-302. PubMed ID: 18081826
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Rituximab in the treatment of high responding inhibitors in severe haemophilia A.
    Moschovi M, Aronis S, Trimis G, Platokouki H, Salavoura K, Tzortzatou-Stathopoulou F.
    Haemophilia; 2006 Jan; 12(1):95-9. PubMed ID: 16409183
    [Abstract] [Full Text] [Related]

  • 16. Analysis of factor VIII inhibitors using hybrid human/porcine factor VIII.
    Lollar P.
    Thromb Haemost; 1997 Jul; 78(1):647-51. PubMed ID: 9198232
    [Abstract] [Full Text] [Related]

  • 17. Identification of plasma antibody epitopes and gene abnormalities in Japanese hemophilia A patients with factor VIII inhibitor.
    Sugihara T, Takahashi I, Kojima T, Okamoto Y, Yamamoto K, Kamiya T, Matsushita T, Saito H.
    Nagoya J Med Sci; 2000 May; 63(1-2):25-39. PubMed ID: 10911718
    [Abstract] [Full Text] [Related]

  • 18. Some factor VIII (FVIII) inhibitors recognise a FVIII epitope(s) that is present only on FVIII-vWF complexes.
    Gilles JG, Lavend'homme R, Peerlinck K, Jacquemin MG, Hoylaerts M, Jorieux S, Mazurier C, Vermylen J, Saint-Remy JM.
    Thromb Haemost; 1999 Jul; 82(1):40-5. PubMed ID: 10456452
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Restricted epitope specificity of anti-FVIII antibodies that appeared during a recent outbreak of inhibitors.
    Gilles JG, Peerlinck K, Arnout J, Vermylen J, Saint-Remy JM.
    Thromb Haemost; 1997 May; 77(5):938-43. PubMed ID: 9184406
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.